Pro Medicus Ltd
ASX:PME
Intrinsic Value
The intrinsic value of one
PME
stock under the Base Case scenario is
16.8
AUD.
Compared to the current market price of 58.47 AUD,
Pro Medicus Ltd
is
Overvalued by 71%.
The Intrinsic Value is calculated as the average of the two valuation methods:
Fundamental Analysis
PME Profitability Score
Profitability Due Diligence
Pro Medicus Ltd's profitability score is 90/100. The higher the profitability score, the more profitable the company is.
Score
Pro Medicus Ltd's profitability score is 90/100. The higher the profitability score, the more profitable the company is.
PME Solvency Score
Solvency Due Diligence
Pro Medicus Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.
Score
Pro Medicus Ltd's solvency score is 73/100. The higher the solvency score, the more solvent the company is.
Balance Sheet Decomposition
Pro Medicus Ltd
PME Capital Structure
Pro Medicus Ltd
| Market Capitalization | 6.1B AUD | |
| Total Debt | 1.7M AUD | |
| Minority Interest | 0 AUD | |
| Preferred Equity | 0 AUD | |
| Cash and Equivalents | 63.7M AUD | |
| Short-Term Investments | 26.9M AUD | |
| Enterprise Value | 6B AUD | |
Wall St
Price Targets
PME Price Targets Summary
Pro Medicus Ltd
According to Wall Street analysts, the average 1-year price target for
PME
is 55.6 AUD
with a low forecast of 37.02 AUD and a high forecast of 65.1 AUD.
Competitive Landscape
PME Competitors
Pro Medicus Ltd
PME Suppliers & Customers
Pro Medicus Ltd
Pro Medicus Ltd has 4 key suppliers from 2 countries and 2 industries. The majority of these suppliers are located in the United States of America, with the largest number of suppliers in the Banking industry.
Pro Medicus Ltd has 4 key customers from 2 countries and 3 industries. The majority of these customers are located in the United States of America, with the largest number of customers in the Banking industry.
Shareholder Return
PME Price
Pro Medicus Ltd
| Average Annual Return | 49.7% |
| Standard Deviation of Annual Returns | 35.91% |
| Max Drawdown | -43% |
| Market Capitalization | 6.1B AUD |
| Shares Outstanding | 103 380 000 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Pro Medicus Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Pro Medicus Ltd. provides a range of radiology information technology software and services to hospitals, imaging centers and health care groups. The company is headquartered in Richmond, Victoria. The company went IPO on 2000-10-10. The firm products include Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro and Visage Ease. Its Visage RIS is a Radiology Information Systems (RIS) medical software for practicing of management, training, installation and professional services, after sale support and service products, Promedicus.net secure email and Integration products. Its Visage 7.0 is a healthcare imaging software that provides radiologists and clinicians with visualization capability for rapidly viewing 2-D, 3-D and 4-D medical images, Picture Archive and Communication System (PACS)/digital imaging software that is sold directly and to original equipment manufacturers (OEM), training, installation and professional services and support products.
Contact
IPO
Employees
Officers
The intrinsic value of one
PME
stock under the Base Case scenario is
16.8
AUD.
Compared to the current market price of 58.47 AUD, Pro Medicus Ltd is Overvalued by 71%.
